Skip to main content

Table 1 Baseline characteristics

From: Heart failure therapy in diabetic patients-comparison with the recent ESC/EASD guideline

  No Diabetes (n = 2310) Diabetes (n = 994) P value for respective effect
      DM EF
  EF <50% (n = 1769) EF ≥ 50% (n = 541) EF <50% (n = 824) EF ≥ 50% (n = 170)   
Female (%) 23.5 49.2 28.9 51.2 0.005 <0.001
Age (years) 61.1 ± 14.3 63.1 ± 14.0 67.2 ± 10.3 69.4 ± 7.6 <0.001 <0.001
Body mass index (kg/m2) 26.9 ± 4.5 28.5 ± 5.1 29.1 ± 5.5 30.3 ± 5.3 <0.001 <0.001
Heart rate (bpm) 73.0 ± 13.5 69.7 ± 12.7 74.2 ± 12.5 72.4 ± 14.4 0.004 <0.001
Systolic blood pressure (mmHg) 121 ± 19 138 ± 23 125 ± 19 140 ± 21 <0.001 <0.001
Diastolic blood pressure (mmHg) 73 ± 11 79 ± 12 73 ± 11 77 ± 13 0.076 <0.001
Glomerular filtration rate (mL/min) 72 ± 24 75 ± 22 64 ± 26 68 ± 24 <0.001 0.002
Hb (mmol/mL) 8.7 ± 1.1 8.7 ± 1.0 8.4 ± 1.2 8.3 ± 1.1 <0.001 0.644
SF-36 score 52 ± 28 59 ± 28 44 ± 28 44 ± 27 <0.001 0.020*
  1. * Significant interaction (p = 0.015) between diabetes and ejection fraction
  2. • DM: Diabetes mellitus, EF: ejection fraction